U.S Class(es): 005, 006, 018, 044, 046, 051, 052
Class Status: Active
Name | Laurence Rickles TEVA PHARMACEUTICALS USA, INC. |
---|---|
Address | 400 INTERPACE PARKWAY BUILDING A PARSIPPANY, NJ 07054 United States |
Date | Description | Action Tags | Code |
---|---|---|---|
Oct-21-2022 | NEW APPLICATION ENTERED | NWAPI | |
Nov-02-2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Mar-28-2023 | ASSIGNED TO EXAMINER | DOCKD | |
Mar-28-2023 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAP | |
Apr-12-2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
May-02-2023 | PUBLISHED FOR OPPOSITION | PUBOA | |
May-02-2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
Jun-27-2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | NOAME | |
Dec-21-2023 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
Dec-21-2023 | SOU EXTENSION 1 FILED | EXT1S | |
Dec-21-2023 | SOU EXTENSION 1 GRANTED | EX1GS | |
Dec-23-2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Jun-18-2024 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
Jun-18-2024 | SOU EXTENSION 2 FILED | EXT2S | |
Jun-18-2024 | SOU EXTENSION 2 GRANTED | EX2GS | |
Jun-18-2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE |